Dr. Hans H. Shuhaiber, MD

Dr. Shuhaiber practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Shuhaiber's NPI, 1144412651, was assigned on August 17, 2007. Dr. Shuhaiber graduated from St. George's University School of Medicine in 2004. Dr. Shuhaiber holds Florida license 117188.

Dr. Shuhaiber's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Shuhaiber's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Shuhaiber to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shuhaiber practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shuhaiber's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Shuhaiber is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Shuhaiber's licenses on file in 10 states: Florida, Maine, California, New York, Illinois, Connecticut, Michigan, New Jersey, District of Columbia and Washington.

CMS data shows 453 Medicare services from Dr. Shuhaiber across 8 procedure codes in 2024, for 235 Medicare patients. Medicare paid $38,769 for them.

CMS counts 235 Medicare patients who saw Dr. Shuhaiber in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shuhaiber's median patient age at 71, with 57% women.

In 2024, Dr. Shuhaiber wrote 746 Medicare Part D claims for 146 patients. 80% of them were for generic drugs. CMS names the drug for 543 of them, across 19 drugs with 11 or more claims each, at $497,809 in total drug cost. In 2023, CMS named 495 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Shuhaiber for performance year 2024, reported through an alternative payment model (APM). Dr. Shuhaiber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shuhaiber as offering telehealth.

Dmand AI links 11 papers to Dr. Shuhaiber, published from 2012 to 2024. 2022 was the busiest year, with 5. Dr. Shuhaiber has published most often in Cureus. Dr. Shuhaiber's most frequent co-authors are Bedirhan Tarhan, MD, Calvin J. Hu, MD and Ana E. Aguilar-Bonilla, MD.

Dmand AI links Dr. Shuhaiber to 2 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Neurofibromatosis 1, Neurofibroma, Plexiform and Neurofibromatoses.

CMS Open Payments shows 23 general payments to Dr. Shuhaiber from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 88% of the total. Alexion Pharmaceuticals, Inc. paid the most, $12,203.

Dr. Shuhaiber graduated from St. George's University School of Medicine in 2004.

Dr. Shuhaiber is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.